Fig. 2From: A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophreniaMean changes in the PANSS negative symptom factor score in the negative symptom group. Abbreviations: LO last observation, W52 Week 52Back to article page